In vivo evaluation of a Poly-2p® barrier cream protective effect

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 6, 2010, Pages 703-708

  Lembo, S ^a   Lembo, C ^a   Lo Conte, V ^a   Gallo, L ^a   La Bella, S ^a   Martellotta, D ^a   Ayala, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Administration, topical; Dermatitis, contact; Treatment outcome

Indexed keywords

CORTICOSTEROID; DODECYL SULFATE SODIUM; HUMECTANT; LIPID; POLY 2P; TOPICAL AGENT; UNCLASSIFIED DRUG; UREA; ZINC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CREAM; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; ERYTHEMA; EXUDATE; FEMALE; HAND DISEASE; HUMAN; IN VIVO STUDY; LICHENOID ERUPTION; PATCH TEST; REMISSION; SCORING SYSTEM; SKIN WATER LOSS; VISCOELASTICITY; XEROSIS;

EID: 79952335973     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990;22:164-78.
2. Buraczewska I, Brostrom U, Lodén M. Artificial reduction in transepidermal water loss improves skin barrier function. Br J Dermatol 2007;157:82-6. (Pubitemid 46934275)
3. Agache PG, Monneur C, Léveque JL, De Rigal J. Mechanical properties and Young's modulus of human skin in vivo. Arch Dermatol Res 1980;269:221-32. (Pubitemid 11207090)
4. Frosch P J, Kurte A, Pilz B. Efficacy of skin barrier creams (III.) The repetitive irritation test (RIT) in humans. Contact Dermatitis 1993;29:113-8. (Pubitemid 23256082)
5. Tupker RA, Willis C, Berardesca E, Lee CH, Fartasch M, Agner T et al. Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1997;37:53-69.
6. Zhai H, Willard P, Maibach H I. Evaluating skin-protective materials against contact irritants and allergens. An in vivo screening human model. Contact Dermatitis 1998;38:155-8. (Pubitemid 28118885)
7. Lati E, Gasser P, Lefeuvre L, Matta AM, Gougerot A. Study of the protective effects of a barrier cream preventing skin penetration of nickel nitrate. Neuv Dermatol 2004;25:1-8.
8. Cristaudo A, Conserva A, Gougerot A, Ionesco TMA, Matta AM, Pellicano M et al. Efficacia e tollerabilità di una crema isolante e riparatrice in soggetti con dermatite da contatto delle mani. Annali italiani di Dermatologia allergologica clinica e sperimentale 2008;62:24-8.
9. Zhai H, Maibach H I. Barrier creams - skin protectants: can you protect skin? J Cosmet Dermatol 2002;1:20-3.
10. Teichmann A, Jacobi U, Waibler E, Sterry W, Lademann J. An in vivo model to evaluate the efficacy of barrier creams on the level of skin penetration of chemicals. Contact Dermatitis 2006;54:5-13.
11. Zhai H, Maibach HI. Effect of barrier creams: human skin in vivo. Contact Dermatitis 1996;35:92-6. (Pubitemid 26385641)
12. Zhai H, Maibach HI. Effects of skin occlusion on percutaneous absorption: An overview. Skin Pharmacol Appl Skin Physiol 2001;14:1-10. (Pubitemid 32098521)
13. Rieger T, Teichmann A, Richter H, Schanzer S, Sterry W, Lademann J. Evaluation of barrier creams - introduction and comparison of 3 in vivo methods. Contact Dermatitis 2007;56:347-54. (Pubitemid 46934357)
14. Frosch PJ, Kurte A. Efficacy of skin barrier creams (IV). The repetitive irritation test (RIT) with a set of 4 standard irritants. Contact Dermatitis 1994;31:161-8.
15. Frosch PJ, Schulze-Dirks A, Hoffmann M, Axthelm I, Kurte A. Efficacy of skin barrier creams (I.) The repetitive irritation test (RIT) in the guinea pig. Contact Dermatitis 1993;28:94-100.
16. Frosch PJ, Schulze-Dirks A, Hoffmann M, Axthelm I. Efficacy of skin barrier creams (II.) Ineffectiveness of a popular 'skin protector' against various irritants in the repetitive irritation test in the guinea pig. Contact Dermatitis 1993;29:74-7.
17. Mellström GA, Boman A. Comparative evaluation of permeation testing of protective gloves to solvents: in vitro in permeation cells versus in vivo in guinea pigs. Contact Dermatitis 1992;26:120-7.